ApiFix Receives FDA Approval to Commercialize MID-C System for Motion-Preserving Deformity Treatment of Progressive Idiopathic Scoliosis in Adolescents

Media coverage

• Title	ApiFix Receives FDA Approval to Commercialize MID-C System for Motion-Preserving Deformity Treatment of Progressive Idiopathic Scoliosis in Adolescents
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	27/08/19
  URL	https://www.biospace.com/article/releases/apifix-receives-fda-approval-to-commercialize-mid-c-system-for-motion-preserving-deformity-treatment-of-progressive-idiopathic-scoliosis-in-adolescents/?s=107
  Persons	Baron Lonner